Chembond Chemicals Share Price: Q2 FY27 Results Watch

Board meeting scheduled for October 24

Chembond Chemicals Limited has scheduled a board meeting for Saturday, October 24, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. The results will cover both standalone and consolidated financial statements. The meeting is a key scheduled corporate event for shareholders tracking Chembond Chemicals share price-related disclosures and the company’s quarterly financial performance. The company informed BSE Limited and the National Stock Exchange of India Limited about the planned meeting. Its October 13 intimation described the agenda as approval of Q2 and H1 FY27 unaudited results. No financial figures for the September quarter were included in the meeting notice.

What the board will consider

The board is expected to consider standalone and consolidated unaudited results for Q2 FY27, covering the three months ended September 30, 2026. It will also consider results for the first half of FY27, which covers the six months ended on that date. The company previously held its June-quarter results meeting on July 16, 2026. At that meeting, the board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were accompanied by a limited review report under Regulation 33 of the SEBI Listing Regulations. The October meeting will provide the next formally scheduled financial update after that June-quarter disclosure.

Trading window remains closed

Chembond Chemicals said the trading window for dealing in its securities will remain closed for directors, officers, designated persons and their immediate relatives. The closure continues until Monday, October 26, 2026, following the board meeting. Such closures are intended to restrict trading by specified persons when unpublished price-sensitive information may be available. The stated period is linked to the forthcoming approval of the September-quarter results. Investors should distinguish this compliance measure from any indication about the company’s financial performance. The filing does not provide a share-price outlook or indicate the expected direction of the results.

FY26 financial reference point

The latest full-year figures provided in the company’s disclosures offer a reference point ahead of the Q2 FY27 announcement. Chembond Chemicals reported consolidated net profit of ₹3,478.03 lakh for FY26. This compared with consolidated net profit of ₹3,091.90 lakh in the preceding year. Revenue from operations for FY26 rose to ₹32,615.06 lakh. These figures relate to the financial year ended March 31, 2026, and should not be read as September-quarter FY27 estimates. The October results will provide the updated reported data for the current financial year.

Key disclosed financial and corporate data

FY26 dividend and annual meeting

In May 2026, the board approved audited standalone and consolidated results for the quarter and financial year ended March 31, 2026. It also recommended a final dividend of ₹1.25 per equity share with a face value of ₹5 each. The recommendation represented 25% of face value and remained subject to shareholder approval. The company scheduled its third Annual General Meeting for July 31, 2026, through video conference. These actions followed the release of the FY26 audited financial statements. The announced October meeting is focused on unaudited Q2 and half-year results rather than a dividend proposal.

Recent results meeting sequence

Chembond Chemicals has maintained a pattern of holding board meetings to approve periodic financial results. Its board met on January 20, 2026, for quarterly results, followed by the May 15 corporate-action listing for audited results and final dividend. A July 15 listing referred to a quarterly-results board meeting, while the outcome announcement states that the June-quarter results were approved on July 16. The latest October meeting notice continues this reporting cycle for the September-ended period. Investors following the company’s disclosures can use the final board outcome and accompanying result documents as the authoritative update.

Demerger and listing context

The company’s earlier disclosures also referred to the completion of a demerger and the consequent listing of its equity shares on BSE and NSE on July 23, 2025. In its July 26, 2025 board-meeting outcome, Chembond Chemicals said the board took note of that completion. The same meeting approved unaudited standalone and consolidated results for the quarter ended June 30, 2025. This corporate history provides context for the company’s listed-entity reporting record. It does not change the scope of the October 2026 meeting, which is confined to reviewing the September 2026 financial results.

What investors can monitor

The upcoming results will be relevant for investors assessing reported revenue, profitability and other disclosed metrics for Q2 and the first half of FY27. The available notice confirms the date, reporting periods and standalone as well as consolidated scope of the review. It does not provide preliminary revenue, profit, margin or operational numbers for the September quarter. Accordingly, conclusions about financial performance should wait for the board-approved results and limited review documentation. The company has also not announced a change to its dividend position in the October meeting intimation. The immediate confirmed milestone is the October 24 board meeting, followed by the end of the stated trading-window closure on October 26.

Conclusion

Chembond Chemicals will review its Q2 and H1 FY27 unaudited results on October 24, 2026. The announcement follows FY26 consolidated revenue of ₹32,615.06 lakh and net profit of ₹3,478.03 lakh. Investors will have clearer reported information once the company releases the board-meeting outcome and financial statements.